Creatinine and BUN levels in the other three groups had no significant differences, indicating Rg3 treatment improved renal function in mice infused Ang II, and prevented nephropathy progression from compensation to decompensation (Figures 6(c) and 6(d)). The gene discussed is AGT; the disease is kidney disorder.